Search our
Current Studies

Still have some questions about the process? Review our Frequently Asked Questions for the answers.
Learn More
Image

This is a Phase 3 randomized double-blind placebo controlled study Assessing the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies in Preventing SARS-Cov-2 Infection in Household Contacts of Individuals Infected with SARS-CoV-2

Location(s): Jacksonville (Headquarters)

Condition: COVID-19

This is a Phase 2a study being done to evaluate the efficacy, safety, PK, and immunogenicity of multiple doses of MEDI3506 in adult subjects with DKD.

Location(s): Jacksonville- LaVilla (Downtown)

Condition:

This study is being done to assess the efficacy and safety of tirzepatide compared to dulaglutide in patients with type 2 diabetes and increased cardiovascular risk.

Location(s): Jacksonville- LaVilla (Downtown), Macon

Condition: Diabetes, Heart Disease

This is a randomized, double-blind, placebo-controlled study to assess the safety, tolerability, efficacy, PK, and PD of the chimeric dopamine-somatostatin receptor agonist, TBR-760, in adult patients with non-functioning pituitary adenomas over 52 weeks

Location(s): Jacksonville (Headquarters)

Condition: Non-Functioning Pituitary Adenoma

ECO-RESET: is a Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Multi-center study to assess the efficacy and safety of SER‑287 in adults with active mild-to-moderate ulcerative colitis

Location(s): St. Augustine

Condition: Ulcerative Colitis

PRECISION: The study is to evaluate the blood pressure lowering effect of aprocitentan when added to other anti-hypertensive drugs of patients with difficult to control (resistant) high blood pressure (hypertension), and to show that blood pressure reduction is kept for long period of time.

Location(s): St. Augustine

Condition: Resistant Hypertension

This randomized, double-blind, placebo controlled, parallel group study being done to provide data on the efficacy, safety, tolerability and pharmacokinetics of multiple dose of PF-06882961 in adults with type 2 diabetes mellitus that are inadequately controlled on metformin and/or diet and exercise.

Location(s): Jacksonville (Headquarters), Jacksonville- LaVilla (Downtown), Macon

Condition: Diabetes

DELIVER Double-blind, Randomized, Placebo-Controlled Phase III Study to Evaluate the Effect of Dapagliflozin on Reducing CV Death or Worsening Heart Failure in Patients with Heart Failure with Preserved Ejection Fraction (HFpEF)

Location(s): St. Augustine

Condition: Heart Failure

Protocol I8F-MC-GPHR(a) A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide versus Placebo in Patients with Nonalcoholic Steatohepatitis (NASH)

Location(s): Jacksonville- LaVilla (Downtown)

Condition: Nonalcoholic Steatohepatitis

The NODE-303 Study: Multi-Centre, Multi-National,Open Label, …

Location(s): St. Augustine

Condition:

SELECT – Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity

Location(s): Jacksonville (Headquarters)

Condition: Heart Disease

A Phase 2b, Multicentre, Randomised, Double-blind, Placebo-controlled Study of Verinurad and Allopurinol in Patients With Chronic KIdney Disease and Hyperuricaemia

Location(s): Jacksonville- LaVilla (Downtown)

Condition: Kidney Disease

A Double-blind Randomized Placebo-controlled Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Atherosclerotic Cardiovascular Disease

Location(s): Jacksonville (Headquarters), Jacksonville- LaVilla (Downtown), Lake CIty, Macon, St. Augustine

Condition: Cholesterol, Heart Disease

A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes (FOCUS)

Location(s): Jacksonville (Headquarters)

Condition: Diabetes

A Multicentre International Randomized Parallel Group Double-blind Placebo-controlled Clinical Trial of EMPAgliflozin Once Daily to Assess Cardio-renal Outcomes in Patients With Chronic KIDNEY Disease

Location(s): Jacksonville (Headquarters), Jacksonville- LaVilla (Downtown), Lake CIty, Macon

Condition: Kidney Disease